Editorial: Application of gene editing in neurodegenerative diseases, volume II.

Qi, Fangfang; Xu, Xingshun; Guo, Xing; Luo, Junhong; Li, Yujing; Yan, Sen

Qi, Fangfang; Xu, Xingshun; Guo, Xing; Luo, Junhong; Li, Yujing; Yan, Sen.

Afiliación

Qi F; Department of Anatomy and Physiology, Guangdong Province Key Laboratory of Brain Function and Disease, Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Xu X; Department of Neurology, Mayo Clinic, Rochester, MN, United States.
Guo X; The Institute of Neuroscience, Soochow University, Suzhou, China.
Luo J; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Li Y; Department of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, China.
Yan S; Department of Human Genetics, Emory University, Atlanta, GA, United States.

Front Neurosci ; 17: 1305302, 2023.

Article en En | MEDLINE | ID: mdl-38027505

Palabras clave

CRISPR/Cas9; adeno-associated virus (AAV); animal model; gene editing; neurodegenerative diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Neurosci Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google